nodes	percent_of_prediction	percent_of_DWPC	metapath
Carbinoxamine—CYP2E1—Dacarbazine—melanoma	0.282	0.348	CbGbCtD
Carbinoxamine—CYP3A4—Temozolomide—melanoma	0.204	0.251	CbGbCtD
Carbinoxamine—CYP2D6—Vemurafenib—melanoma	0.176	0.216	CbGbCtD
Carbinoxamine—CYP3A4—Vemurafenib—melanoma	0.112	0.138	CbGbCtD
Carbinoxamine—CYP3A4—Docetaxel—melanoma	0.0383	0.0472	CbGbCtD
Carbinoxamine—Photosensitivity—Vemurafenib—melanoma	0.00488	0.0333	CcSEcCtD
Carbinoxamine—Chest tightness—Docetaxel—melanoma	0.00428	0.0292	CcSEcCtD
Carbinoxamine—Wheezing—Bleomycin—melanoma	0.00347	0.0237	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Vemurafenib—melanoma	0.00338	0.0231	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Vemurafenib—melanoma	0.00324	0.0221	CcSEcCtD
Carbinoxamine—Neuritis—Docetaxel—melanoma	0.00269	0.0184	CcSEcCtD
Carbinoxamine—Chills—Vemurafenib—melanoma	0.00266	0.0182	CcSEcCtD
Carbinoxamine—Nasal congestion—Temozolomide—melanoma	0.0024	0.0164	CcSEcCtD
Carbinoxamine—Chest discomfort—Docetaxel—melanoma	0.00227	0.0155	CcSEcCtD
Carbinoxamine—Diplopia—Carmustine—melanoma	0.00227	0.0155	CcSEcCtD
Carbinoxamine—Diplopia—Temozolomide—melanoma	0.00219	0.015	CcSEcCtD
Carbinoxamine—Hypotension—Vemurafenib—melanoma	0.00197	0.0134	CcSEcCtD
Carbinoxamine—Sweating increased—Temozolomide—melanoma	0.00184	0.0126	CcSEcCtD
Carbinoxamine—Decreased appetite—Vemurafenib—melanoma	0.00183	0.0125	CcSEcCtD
Carbinoxamine—Fatigue—Vemurafenib—melanoma	0.00182	0.0124	CcSEcCtD
Carbinoxamine—Constipation—Vemurafenib—melanoma	0.0018	0.0123	CcSEcCtD
Carbinoxamine—Pollakiuria—Temozolomide—melanoma	0.00175	0.0119	CcSEcCtD
Carbinoxamine—Agranulocytosis—Dactinomycin—melanoma	0.00174	0.0119	CcSEcCtD
Carbinoxamine—Photosensitivity reaction—Temozolomide—melanoma	0.00173	0.0118	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Carmustine—melanoma	0.00171	0.0117	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Temozolomide—melanoma	0.00165	0.0113	CcSEcCtD
Carbinoxamine—Chills—Bleomycin—melanoma	0.00161	0.011	CcSEcCtD
Carbinoxamine—Asthenia—Vemurafenib—melanoma	0.00151	0.0103	CcSEcCtD
Carbinoxamine—Chills—Dactinomycin—melanoma	0.0015	0.0103	CcSEcCtD
Carbinoxamine—Diarrhoea—Vemurafenib—melanoma	0.00144	0.00984	CcSEcCtD
Carbinoxamine—Tinnitus—Temozolomide—melanoma	0.00141	0.00965	CcSEcCtD
Carbinoxamine—Dizziness—Vemurafenib—melanoma	0.00139	0.00951	CcSEcCtD
Carbinoxamine—Chills—Temozolomide—melanoma	0.00136	0.00929	CcSEcCtD
Carbinoxamine—Vomiting—Vemurafenib—melanoma	0.00134	0.00915	CcSEcCtD
Carbinoxamine—Headache—Vemurafenib—melanoma	0.00132	0.00901	CcSEcCtD
Carbinoxamine—Confusional state—Bleomycin—melanoma	0.00129	0.00879	CcSEcCtD
Carbinoxamine—Vision blurred—Carmustine—melanoma	0.00129	0.00879	CcSEcCtD
Carbinoxamine—Tremor—Carmustine—melanoma	0.00128	0.00873	CcSEcCtD
Carbinoxamine—Agitation—Carmustine—melanoma	0.00125	0.00857	CcSEcCtD
Carbinoxamine—Nausea—Vemurafenib—melanoma	0.00125	0.00855	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Bleomycin—melanoma	0.00125	0.00853	CcSEcCtD
Carbinoxamine—Vision blurred—Temozolomide—melanoma	0.00124	0.00849	CcSEcCtD
Carbinoxamine—Tremor—Temozolomide—melanoma	0.00124	0.00844	CcSEcCtD
Carbinoxamine—Anorexia—Bleomycin—melanoma	0.00122	0.00831	CcSEcCtD
Carbinoxamine—Agitation—Temozolomide—melanoma	0.00121	0.00828	CcSEcCtD
Carbinoxamine—Hypotension—Bleomycin—melanoma	0.00119	0.00815	CcSEcCtD
Carbinoxamine—Vertigo—Temozolomide—melanoma	0.00118	0.00809	CcSEcCtD
Carbinoxamine—Convulsion—Carmustine—melanoma	0.00118	0.00808	CcSEcCtD
Carbinoxamine—Palpitations—Temozolomide—melanoma	0.00117	0.00796	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Dactinomycin—melanoma	0.00117	0.00796	CcSEcCtD
Carbinoxamine—Paraesthesia—Bleomycin—melanoma	0.00115	0.00783	CcSEcCtD
Carbinoxamine—Convulsion—Temozolomide—melanoma	0.00114	0.00781	CcSEcCtD
Carbinoxamine—Anorexia—Dactinomycin—melanoma	0.00113	0.00775	CcSEcCtD
Carbinoxamine—Confusional state—Carmustine—melanoma	0.00112	0.00767	CcSEcCtD
Carbinoxamine—Decreased appetite—Bleomycin—melanoma	0.00111	0.00758	CcSEcCtD
Carbinoxamine—Neuropathy peripheral—Docetaxel—melanoma	0.0011	0.00752	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Carmustine—melanoma	0.00109	0.00745	CcSEcCtD
Carbinoxamine—Tachycardia—Carmustine—melanoma	0.00109	0.00743	CcSEcCtD
Carbinoxamine—Confusional state—Temozolomide—melanoma	0.00109	0.00741	CcSEcCtD
Carbinoxamine—Anorexia—Carmustine—melanoma	0.00106	0.00725	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Temozolomide—melanoma	0.00105	0.0072	CcSEcCtD
Carbinoxamine—Feeling abnormal—Bleomycin—melanoma	0.00105	0.00718	CcSEcCtD
Carbinoxamine—Agranulocytosis—Docetaxel—melanoma	0.00105	0.00715	CcSEcCtD
Carbinoxamine—Hypotension—Carmustine—melanoma	0.00104	0.00711	CcSEcCtD
Carbinoxamine—Hyperhidrosis—Temozolomide—melanoma	0.00104	0.00711	CcSEcCtD
Carbinoxamine—Decreased appetite—Dactinomycin—melanoma	0.00103	0.00707	CcSEcCtD
Carbinoxamine—Fatigue—Dactinomycin—melanoma	0.00103	0.00701	CcSEcCtD
Carbinoxamine—Anorexia—Temozolomide—melanoma	0.00103	0.00701	CcSEcCtD
Carbinoxamine—Urticaria—Bleomycin—melanoma	0.00101	0.00692	CcSEcCtD
Carbinoxamine—Insomnia—Carmustine—melanoma	0.00101	0.00688	CcSEcCtD
Carbinoxamine—Paraesthesia—Carmustine—melanoma	0.001	0.00683	CcSEcCtD
Carbinoxamine—Somnolence—Carmustine—melanoma	0.00099	0.00676	CcSEcCtD
Carbinoxamine—Feeling abnormal—Dactinomycin—melanoma	0.000981	0.0067	CcSEcCtD
Carbinoxamine—Insomnia—Temozolomide—melanoma	0.000973	0.00665	CcSEcCtD
Carbinoxamine—Decreased appetite—Carmustine—melanoma	0.000968	0.00661	CcSEcCtD
Carbinoxamine—Paraesthesia—Temozolomide—melanoma	0.000966	0.0066	CcSEcCtD
Carbinoxamine—Somnolence—Temozolomide—melanoma	0.000957	0.00654	CcSEcCtD
Carbinoxamine—Constipation—Carmustine—melanoma	0.000952	0.00651	CcSEcCtD
Carbinoxamine—Dyspepsia—Temozolomide—melanoma	0.000947	0.00647	CcSEcCtD
Carbinoxamine—Decreased appetite—Temozolomide—melanoma	0.000936	0.00639	CcSEcCtD
Carbinoxamine—Fatigue—Temozolomide—melanoma	0.000928	0.00634	CcSEcCtD
Carbinoxamine—Constipation—Temozolomide—melanoma	0.00092	0.00629	CcSEcCtD
Carbinoxamine—Feeling abnormal—Carmustine—melanoma	0.000918	0.00627	CcSEcCtD
Carbinoxamine—Asthenia—Bleomycin—melanoma	0.000915	0.00625	CcSEcCtD
Carbinoxamine—Chills—Docetaxel—melanoma	0.000904	0.00618	CcSEcCtD
Carbinoxamine—Feeling abnormal—Temozolomide—melanoma	0.000887	0.00606	CcSEcCtD
Carbinoxamine—Urticaria—Temozolomide—melanoma	0.000855	0.00584	CcSEcCtD
Carbinoxamine—Asthenia—Dactinomycin—melanoma	0.000854	0.00583	CcSEcCtD
Carbinoxamine—Diarrhoea—Dactinomycin—melanoma	0.000814	0.00556	CcSEcCtD
Carbinoxamine—Vomiting—Bleomycin—melanoma	0.000811	0.00554	CcSEcCtD
Carbinoxamine—Asthenia—Carmustine—melanoma	0.000799	0.00546	CcSEcCtD
Carbinoxamine—Palpitations—Docetaxel—melanoma	0.000775	0.00529	CcSEcCtD
Carbinoxamine—Asthenia—Temozolomide—melanoma	0.000772	0.00528	CcSEcCtD
Carbinoxamine—Diarrhoea—Carmustine—melanoma	0.000762	0.00521	CcSEcCtD
Carbinoxamine—Convulsion—Docetaxel—melanoma	0.00076	0.00519	CcSEcCtD
Carbinoxamine—Nausea—Bleomycin—melanoma	0.000758	0.00518	CcSEcCtD
Carbinoxamine—Vomiting—Dactinomycin—melanoma	0.000757	0.00517	CcSEcCtD
Carbinoxamine—Dizziness—Carmustine—melanoma	0.000736	0.00503	CcSEcCtD
Carbinoxamine—Diarrhoea—Temozolomide—melanoma	0.000736	0.00503	CcSEcCtD
Carbinoxamine—Confusional state—Docetaxel—melanoma	0.000722	0.00493	CcSEcCtD
Carbinoxamine—Dizziness—Temozolomide—melanoma	0.000712	0.00486	CcSEcCtD
Carbinoxamine—Vomiting—Carmustine—melanoma	0.000708	0.00484	CcSEcCtD
Carbinoxamine—Nausea—Dactinomycin—melanoma	0.000707	0.00483	CcSEcCtD
Carbinoxamine—Thrombocytopenia—Docetaxel—melanoma	0.000701	0.00479	CcSEcCtD
Carbinoxamine—Tachycardia—Docetaxel—melanoma	0.000699	0.00477	CcSEcCtD
Carbinoxamine—Headache—Carmustine—melanoma	0.000698	0.00477	CcSEcCtD
Carbinoxamine—Vomiting—Temozolomide—melanoma	0.000684	0.00468	CcSEcCtD
Carbinoxamine—Anorexia—Docetaxel—melanoma	0.000682	0.00466	CcSEcCtD
Carbinoxamine—Headache—Temozolomide—melanoma	0.000674	0.00461	CcSEcCtD
Carbinoxamine—Hypotension—Docetaxel—melanoma	0.000669	0.00457	CcSEcCtD
Carbinoxamine—Nausea—Carmustine—melanoma	0.000661	0.00452	CcSEcCtD
Carbinoxamine—Insomnia—Docetaxel—melanoma	0.000647	0.00442	CcSEcCtD
Carbinoxamine—Paraesthesia—Docetaxel—melanoma	0.000643	0.00439	CcSEcCtD
Carbinoxamine—Nausea—Temozolomide—melanoma	0.000639	0.00437	CcSEcCtD
Carbinoxamine—Somnolence—Docetaxel—melanoma	0.000636	0.00435	CcSEcCtD
Carbinoxamine—Dyspepsia—Docetaxel—melanoma	0.00063	0.0043	CcSEcCtD
Carbinoxamine—Decreased appetite—Docetaxel—melanoma	0.000622	0.00425	CcSEcCtD
Carbinoxamine—Fatigue—Docetaxel—melanoma	0.000617	0.00422	CcSEcCtD
Carbinoxamine—Constipation—Docetaxel—melanoma	0.000612	0.00418	CcSEcCtD
Carbinoxamine—Feeling abnormal—Docetaxel—melanoma	0.00059	0.00403	CcSEcCtD
Carbinoxamine—Asthenia—Docetaxel—melanoma	0.000513	0.00351	CcSEcCtD
Carbinoxamine—Diarrhoea—Docetaxel—melanoma	0.00049	0.00335	CcSEcCtD
Carbinoxamine—Dizziness—Docetaxel—melanoma	0.000473	0.00323	CcSEcCtD
Carbinoxamine—Vomiting—Docetaxel—melanoma	0.000455	0.00311	CcSEcCtD
Carbinoxamine—Headache—Docetaxel—melanoma	0.000448	0.00306	CcSEcCtD
Carbinoxamine—Nausea—Docetaxel—melanoma	0.000425	0.0029	CcSEcCtD
Carbinoxamine—CYP2E1—Metabolism—FASN—melanoma	1.47e-05	0.000348	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC6A11—melanoma	1.46e-05	0.000348	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIP4K2A—melanoma	1.46e-05	0.000348	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—VCAN—melanoma	1.45e-05	0.000345	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—SLC5A5—melanoma	1.44e-05	0.000343	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—MTAP—melanoma	1.42e-05	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—GNAQ—melanoma	1.42e-05	0.000338	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CD44—melanoma	1.42e-05	0.000338	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCR4—melanoma	1.41e-05	0.000334	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FOXO4—melanoma	1.41e-05	0.000334	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HDAC2—melanoma	1.41e-05	0.000334	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—GNAQ—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CD44—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—GNAQ—melanoma	1.39e-05	0.000331	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.37e-05	0.000326	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP17A1—melanoma	1.37e-05	0.000326	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—CYP1B1—melanoma	1.36e-05	0.000324	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.35e-05	0.000321	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CG—melanoma	1.34e-05	0.000318	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—CYP1B1—melanoma	1.34e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—melanoma	1.34e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—VCAN—melanoma	1.34e-05	0.000317	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.33e-05	0.000315	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—VCAN—melanoma	1.32e-05	0.000314	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SYK—melanoma	1.31e-05	0.000311	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CD—melanoma	1.3e-05	0.000308	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GNA11—melanoma	1.3e-05	0.000308	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NGFR—melanoma	1.28e-05	0.000305	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT3—melanoma	1.28e-05	0.000305	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ITGAV—melanoma	1.28e-05	0.000305	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PHGDH—melanoma	1.27e-05	0.000301	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—LUM—melanoma	1.27e-05	0.000301	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—FASN—melanoma	1.27e-05	0.000301	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	1.25e-05	0.000298	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—SLC5A5—melanoma	1.25e-05	0.000296	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—HPSE—melanoma	1.25e-05	0.000296	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP17A1—melanoma	1.22e-05	0.000291	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CUBN—melanoma	1.22e-05	0.00029	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	1.21e-05	0.000287	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.21e-05	0.000287	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—GNAQ—melanoma	1.2e-05	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CD44—melanoma	1.2e-05	0.000286	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	1.19e-05	0.000283	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SOCS1—melanoma	1.19e-05	0.000282	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAP2K1—melanoma	1.19e-05	0.000282	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—S100B—melanoma	1.19e-05	0.000282	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CSPG4—melanoma	1.18e-05	0.00028	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—BSG—melanoma	1.18e-05	0.00028	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SDHD—melanoma	1.18e-05	0.00028	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.18e-05	0.00028	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CD—melanoma	1.18e-05	0.00028	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.17e-05	0.000278	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNA11—melanoma	1.16e-05	0.000275	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—CYP1B1—melanoma	1.16e-05	0.000274	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GPAM—melanoma	1.14e-05	0.000271	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB4—melanoma	1.13e-05	0.000269	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—FASN—melanoma	1.13e-05	0.000269	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CB—melanoma	1.13e-05	0.000269	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP17A1—melanoma	1.13e-05	0.000267	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN2B—melanoma	1.12e-05	0.000267	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ABCB1—melanoma	1.12e-05	0.000267	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP17A1—melanoma	1.12e-05	0.000265	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—SLC5A5—melanoma	1.11e-05	0.000264	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.1e-05	0.000262	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ABCB1—melanoma	1.1e-05	0.000261	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CD86—melanoma	1.09e-05	0.000258	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—CXCL8—melanoma	1.09e-05	0.000258	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	1.09e-05	0.000258	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EDN1—melanoma	1.08e-05	0.000256	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—GNAQ—melanoma	1.08e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CD44—melanoma	1.08e-05	0.000255	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNA11—melanoma	1.06e-05	0.000253	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF1—melanoma	1.06e-05	0.00025	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CSF2—melanoma	1.06e-05	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNA11—melanoma	1.05e-05	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.05e-05	0.00025	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.04e-05	0.000248	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—FASN—melanoma	1.04e-05	0.000247	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—IL2—melanoma	1.04e-05	0.000247	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PRKCA—melanoma	1.03e-05	0.000245	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—E2F1—melanoma	1.03e-05	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—FASN—melanoma	1.03e-05	0.000245	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—CYP1B1—melanoma	1.03e-05	0.000245	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CB—melanoma	1.03e-05	0.000244	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ERCC2—melanoma	1.03e-05	0.000243	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—SLC5A5—melanoma	1.02e-05	0.000243	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PDGFRA—melanoma	1.02e-05	0.000243	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.02e-05	0.000242	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—SLC5A5—melanoma	1.02e-05	0.000241	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PRKCA—melanoma	1.01e-05	0.00024	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ITGB3—melanoma	1.01e-05	0.00024	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PRKCA—melanoma	1.01e-05	0.00024	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ERCC2—melanoma	1e-05	0.000238	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—SPP1—melanoma	9.92e-06	0.000236	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—GNAQ—melanoma	9.89e-06	0.000235	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CD44—melanoma	9.89e-06	0.000235	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAP2K2—melanoma	9.89e-06	0.000235	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—CXCL8—melanoma	9.88e-06	0.000234	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CD44—melanoma	9.81e-06	0.000233	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—GNAQ—melanoma	9.81e-06	0.000233	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PLA2G6—melanoma	9.72e-06	0.000231	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	9.6e-06	0.000228	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	9.51e-06	0.000226	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ABCB1—melanoma	9.51e-06	0.000226	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—CYP1B1—melanoma	9.48e-06	0.000225	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL2—melanoma	9.44e-06	0.000224	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TERT—melanoma	9.4e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—CYP1B1—melanoma	9.4e-06	0.000223	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—RAC1—melanoma	9.38e-06	0.000223	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	9.1e-06	0.000216	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HIF1A—melanoma	8.99e-06	0.000214	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PRKCA—melanoma	8.75e-06	0.000208	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—VCAN—melanoma	8.73e-06	0.000207	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ERCC2—melanoma	8.68e-06	0.000206	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KDR—melanoma	8.6e-06	0.000204	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ABCB1—melanoma	8.49e-06	0.000202	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	8.3e-06	0.000197	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FN1—melanoma	8.28e-06	0.000197	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NOTCH1—melanoma	8.1e-06	0.000192	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CG—melanoma	8.1e-06	0.000192	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CD80—melanoma	7.94e-06	0.000188	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CG—melanoma	7.93e-06	0.000188	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KIT—melanoma	7.92e-06	0.000188	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CG—melanoma	7.92e-06	0.000188	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—APC—melanoma	7.92e-06	0.000188	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—NRAS—melanoma	7.92e-06	0.000188	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGF—melanoma	7.83e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PPARG—melanoma	7.82e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PRKCA—melanoma	7.81e-06	0.000186	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ABCB1—melanoma	7.81e-06	0.000185	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ERCC2—melanoma	7.75e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ABCB1—melanoma	7.74e-06	0.000184	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PPARG—melanoma	7.66e-06	0.000182	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK3—melanoma	7.59e-06	0.00018	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—BRAF—melanoma	7.45e-06	0.000177	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP17A1—melanoma	7.37e-06	0.000175	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IGF1—melanoma	7.25e-06	0.000172	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—MAPK1—melanoma	7.22e-06	0.000171	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—EGFR—melanoma	7.22e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	7.19e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PRKCA—melanoma	7.19e-06	0.000171	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ERCC2—melanoma	7.13e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PRKCA—melanoma	7.12e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CD—melanoma	7.12e-06	0.000169	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ERCC2—melanoma	7.07e-06	0.000168	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—ALB—melanoma	7.03e-06	0.000167	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAP2K1—melanoma	7.01e-06	0.000166	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CD—melanoma	6.97e-06	0.000166	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CD—melanoma	6.97e-06	0.000165	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNA11—melanoma	6.96e-06	0.000165	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—PIK3CA—melanoma	6.9e-06	0.000164	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—ALB—melanoma	6.88e-06	0.000163	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CG—melanoma	6.86e-06	0.000163	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—KRAS—melanoma	6.82e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—FASN—melanoma	6.81e-06	0.000162	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—SLC5A5—melanoma	6.7e-06	0.000159	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—FGF2—melanoma	6.67e-06	0.000158	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PPARG—melanoma	6.62e-06	0.000157	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CD44—melanoma	6.47e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—GNAQ—melanoma	6.47e-06	0.000154	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	6.42e-06	0.000152	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—PIK3CA—melanoma	6.26e-06	0.000149	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MDM2—melanoma	6.24e-06	0.000148	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CB—melanoma	6.21e-06	0.000147	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—CYP1B1—melanoma	6.2e-06	0.000147	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—ERBB2—melanoma	6.15e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTGS2—melanoma	6.15e-06	0.000146	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CG—melanoma	6.12e-06	0.000145	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CB—melanoma	6.08e-06	0.000144	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CB—melanoma	6.07e-06	0.000144	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CD—melanoma	6.03e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTGS2—melanoma	6.02e-06	0.000143	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—ALB—melanoma	5.95e-06	0.000141	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PPARG—melanoma	5.91e-06	0.00014	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.85e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CXCL8—melanoma	5.83e-06	0.000139	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—HRAS—melanoma	5.8e-06	0.000138	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1B—melanoma	5.7e-06	0.000135	CbGpPWpGaD
Carbinoxamine—HRH1—GPCR downstream signaling—AKT1—melanoma	5.64e-06	0.000134	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CG—melanoma	5.63e-06	0.000134	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CASP3—melanoma	5.58e-06	0.000133	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CG—melanoma	5.58e-06	0.000132	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL2—melanoma	5.58e-06	0.000132	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—IL6—melanoma	5.55e-06	0.000132	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CCND1—melanoma	5.44e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PPARG—melanoma	5.43e-06	0.000129	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PPARG—melanoma	5.39e-06	0.000128	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CTNNB1—melanoma	5.38e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CD—melanoma	5.38e-06	0.000128	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PTEN—melanoma	5.36e-06	0.000127	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—ALB—melanoma	5.31e-06	0.000126	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MMP9—melanoma	5.28e-06	0.000125	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—CDKN1A—melanoma	5.26e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CB—melanoma	5.25e-06	0.000125	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PTEN—melanoma	5.25e-06	0.000125	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PTEN—melanoma	5.25e-06	0.000125	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NFKB1—melanoma	5.22e-06	0.000124	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTGS2—melanoma	5.21e-06	0.000124	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling by GPCR—AKT1—melanoma	5.12e-06	0.000122	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ABCB1—melanoma	5.11e-06	0.000121	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CD—melanoma	4.95e-06	0.000117	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CD—melanoma	4.91e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—ALB—melanoma	4.89e-06	0.000116	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—ALB—melanoma	4.84e-06	0.000115	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—VEGFA—melanoma	4.74e-06	0.000112	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PRKCA—melanoma	4.7e-06	0.000112	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—STAT3—melanoma	4.69e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CB—melanoma	4.69e-06	0.000111	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—NRAS—melanoma	4.68e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ERCC2—melanoma	4.66e-06	0.000111	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTGS2—melanoma	4.65e-06	0.00011	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PTEN—melanoma	4.54e-06	0.000108	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK3—melanoma	4.48e-06	0.000106	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MYC—melanoma	4.36e-06	0.000104	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CB—melanoma	4.31e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CB—melanoma	4.28e-06	0.000102	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTGS2—melanoma	4.27e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—MAPK1—melanoma	4.26e-06	0.000101	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—EGFR—melanoma	4.26e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTGS2—melanoma	4.24e-06	0.000101	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PTEN—melanoma	4.05e-06	9.62e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—KRAS—melanoma	4.03e-06	9.56e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—PIK3CA—melanoma	3.78e-06	8.98e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PTEN—melanoma	3.73e-06	8.85e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—PIK3CA—melanoma	3.71e-06	8.8e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—PIK3CA—melanoma	3.7e-06	8.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PTEN—melanoma	3.7e-06	8.77e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CG—melanoma	3.68e-06	8.74e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—TP53—melanoma	3.58e-06	8.5e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PPARG—melanoma	3.55e-06	8.43e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—HRAS—melanoma	3.42e-06	8.13e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—IL6—melanoma	3.28e-06	7.78e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CD—melanoma	3.24e-06	7.68e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—PIK3CA—melanoma	3.2e-06	7.6e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—ALB—melanoma	3.19e-06	7.58e-05	CbGpPWpGaD
Carbinoxamine—CYP2B6—Metabolism—AKT1—melanoma	3.09e-06	7.34e-05	CbGpPWpGaD
Carbinoxamine—CYP2E1—Metabolism—AKT1—melanoma	3.03e-06	7.19e-05	CbGpPWpGaD
Carbinoxamine—HRH1—Signaling Pathways—AKT1—melanoma	3.02e-06	7.18e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—PIK3CA—melanoma	2.86e-06	6.79e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CB—melanoma	2.82e-06	6.7e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTGS2—melanoma	2.79e-06	6.63e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—PIK3CA—melanoma	2.63e-06	6.24e-05	CbGpPWpGaD
Carbinoxamine—CYP2C8—Metabolism—AKT1—melanoma	2.62e-06	6.21e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—PIK3CA—melanoma	2.61e-06	6.19e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PTEN—melanoma	2.44e-06	5.79e-05	CbGpPWpGaD
Carbinoxamine—CYP2C19—Metabolism—AKT1—melanoma	2.34e-06	5.54e-05	CbGpPWpGaD
Carbinoxamine—CYP2D6—Metabolism—AKT1—melanoma	2.15e-06	5.1e-05	CbGpPWpGaD
Carbinoxamine—CYP2C9—Metabolism—AKT1—melanoma	2.13e-06	5.06e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—PIK3CA—melanoma	1.72e-06	4.08e-05	CbGpPWpGaD
Carbinoxamine—CYP3A4—Metabolism—AKT1—melanoma	1.4e-06	3.33e-05	CbGpPWpGaD
